Latest Breaking News On - Nguyen quoc thai - Page 1 : comparemela.com

Bayer Vietnam leads advances in management of peripheral artery disease 15:27 | 13/01/2021 With new progress in the management in peripheral artery disease (PAD), Bayer has introduced the new indication of non-Vitamin K antagonist anticoagulant (NOAC) as an effective treatment for PAD patients in Vietnam. MD. MBA Tran Thi Lan Huong, Medical Director at Bayer Vietnam delivered welcome remarks at the hybrid medical scientific event “New Progress in the Management of Peripheral Artery Disease” On this occasion, Bayer has collaborated with Bach Mai Hospital to organise a hybrid medical scientific event for the medical community specialising in cardiology and vascular medicine, called New Progress in the Management of Peripheral Artery Disease. The seminar was held in both Hanoi and Ho Chi Minh City, as well as was broadcast online at the same time, providing a forum to discuss medical practices, unmet needs, and recent scientific data relate

Han iRepublic ofBach maiHo chi minh cityH chíinhSociety of vascular surgeryCardiology instituteEuropean society of cardiologyEuropean medicines agencyWorld federation of vascular societiesDeputy head of the department vascular surgeryEuropean society for vascular surgeryBayer vietnamThi lan huongMedical directorPeripheral artery